Showing results (411-420 of 757) with videos related to
Sort By:
Pageof 76
Diabetes & Vascular Disease Research|January 16, 2015
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trialsSilvio E Inzucchi, Bernard Zinman, Christoph Wanner, et al.Circulation. Heart Failure|June 6, 2019
Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart FailureJaved Butler, Faiez Zannad, David Fitchett, et al.Journal of the American Heart Association|October 31, 2019
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease PatientsNicholas C Chesnaye, Karolina Szummer, Peter Bárány, et al.Journal of the American Society of Hypertension : JASH|August 1, 2017
The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitusJens Jordan, Jens Tank, Karsten Heusser, et al.JACC. Heart Failure|July 30, 2021
Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME TrialAbhinav Sharma, Anne Pernille Ofstad, Tariq Ahmad, et al.Kidney International|June 6, 2003
L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in ratsReinhard Schneider, Ulrike Raff, Nicole Vornberger, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 23, 2009
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry RegistryAlberto Ortiz, Bruno Cianciaruso, Marta Cizmarik, et al.European Journal of Human Genetics : EJHG|December 8, 2005
Hidden population substructures in an apparently homogeneous population bias association studiesMario Berger, Hans H Stassen, Karola Köhler, et al.Circulation|August 25, 2010
Homoarginine, cardiovascular risk, and mortalityWinfried März, Andreas Meinitzer, Christiane Drechsler, et al.Plos One|April 16, 2015
Heart failure in a cohort of patients with chronic kidney disease: the GCKD studyHanna Beck, Stephanie I Titze, Silvia Hübner, et al.Pageof 76